Skip to main content
Erschienen in: Obesity Surgery 7/2017

13.01.2017 | Original Contributions

Milestone Weight Loss Goals (Weight Normalization and Remission of Obesity) after Gastric Bypass Surgery: Long-Term Results from the University of Michigan

verfasst von: Corey J. Lager, Nazanene H. Esfandiari, Angela R. Subauste, Andrew T. Kraftson, Morton B. Brown, Ruth B. Cassidy, Darlene Bellers, Amy L. Lockwood, Oliver A. Varban, Elif A. Oral

Erschienen in: Obesity Surgery | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Rates of weight normalization and obesity remission after Roux-en-Y gastric bypass (GB) are unknown. This study evaluated weight loss, rates of achieving body mass index (BMI) <25 or 30 kg/m2, recidivism, and predictors of success following GB.

Methods

We retrospectively studied weight and BMI at baseline, 2 and 6 months, and annually at 1–7 years in 219 patients undergoing GB at the University of Michigan from January 2008 to November 2010.

Results

Follow-up was excellent for a population traditionally associated with high attrition rates with data availability of 157/219, 145/219, 144/219, 134/219, 123/219, 82/161, and 29/64 patients at 1–7 years, respectively. Mean baseline BMI was 47.0 kg/m2. Weight normalization (BMI <25 kg/m2) occurred in 2.3–6.8% of patients. More importantly, 47% of patients achieved remission of obesity (BMI <30 kg/m2) at some time point and 24% (52/219) at the last observed time point. BMI <30 kg/m2 was associated with a lower initial BMI and follow-up for more than 2 years.

Conclusions

Rates of weight normalization are low after GB; however, a large number of patients achieved BMI <30 kg/m2. While the percent total weight loss and excess weight loss are both quite high in the entire cohort and this is likely associated with significant health benefits, our results still underscore the need to address obesity with intensive clinical attention earlier in its course.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81.CrossRefPubMedPubMedCentral Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Fildes A, Charlton J, Rudisill C, et al. Probability of an obese person attaining normal body weight: cohort study using electronic health records. Am J Public Health. 2015;105(9):e54–9.CrossRefPubMedPubMedCentral Fildes A, Charlton J, Rudisill C, et al. Probability of an obese person attaining normal body weight: cohort study using electronic health records. Am J Public Health. 2015;105(9):e54–9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Booth HP, Prevost TA, Wright AJ, et al. Effectiveness of behavioural weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis. Fam Pract. 2014;31(6):643–53.CrossRefPubMedPubMedCentral Booth HP, Prevost TA, Wright AJ, et al. Effectiveness of behavioural weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis. Fam Pract. 2014;31(6):643–53.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Rothberg AE, McEwen LN, Kraftson AT, et al. Very-low-energy diet for type 2 diabetes: an underutilized therapy? J Diabetes Complicat. 2014;28(4):506–10.CrossRefPubMedPubMedCentral Rothberg AE, McEwen LN, Kraftson AT, et al. Very-low-energy diet for type 2 diabetes: an underutilized therapy? J Diabetes Complicat. 2014;28(4):506–10.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat König D, Zdzieblik D, Deibert P, et al. Internal fat and Cardiometabolic risk factors following a meal-replacement regimen vs. comprehensive lifestyle changes in obese subjects. Nutrients. 2015;7(12):9825–33.CrossRefPubMedPubMedCentral König D, Zdzieblik D, Deibert P, et al. Internal fat and Cardiometabolic risk factors following a meal-replacement regimen vs. comprehensive lifestyle changes in obese subjects. Nutrients. 2015;7(12):9825–33.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014;149(7):707–15.CrossRefPubMedPubMedCentral Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014;149(7):707–15.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.CrossRefPubMed Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.CrossRefPubMed
9.
Zurück zum Zitat Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716–26.CrossRefPubMedPubMedCentral Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716–26.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass versus intensive medical Management for the Control of type 2 diabetes, hypertension and hyperlipidemia: an international, multicenter, randomized trial. JAMA : the journal of the American Medical Association. 2013;309(21):2240–9.CrossRefPubMed Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass versus intensive medical Management for the Control of type 2 diabetes, hypertension and hyperlipidemia: an international, multicenter, randomized trial. JAMA : the journal of the American Medical Association. 2013;309(21):2240–9.CrossRefPubMed
11.
Zurück zum Zitat Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.CrossRefPubMed Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.CrossRefPubMed
12.
Zurück zum Zitat Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.CrossRefPubMedPubMedCentral Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Schauer PRBD, Kirwan J. Bariatric surgery vs. intensive medical therapy for long-term glycemic control and complications of diabetes: final 5-year STAMPEDE trial results. Chicago: American College of Cardiology 2016 Scientific Sessions; 2016. Schauer PRBD, Kirwan J. Bariatric surgery vs. intensive medical therapy for long-term glycemic control and complications of diabetes: final 5-year STAMPEDE trial results. Chicago: American College of Cardiology 2016 Scientific Sessions; 2016.
14.
Zurück zum Zitat Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ (Clinical research ed). 2016;353:i2156. Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ (Clinical research ed). 2016;353:i2156.
15.
Zurück zum Zitat Lager CJ, Esfandiari NH, Subauste AR, et al. Roux-En-Y gastric bypass vs. sleeve gastrectomy: balancing the risks of surgery with the benefits of weight loss. Obes Surg. 2017 Jan;27(1):154-161. doi:10.1007/s11695-016-2265-2. Lager CJ, Esfandiari NH, Subauste AR, et al. Roux-En-Y gastric bypass vs. sleeve gastrectomy: balancing the risks of surgery with the benefits of weight loss. Obes Surg. 2017 Jan;27(1):154-161. doi:10.​1007/​s11695-016-2265-2.
16.
Zurück zum Zitat Christou NV. Impact of obesity and bariatric surgery on survival. World J Surg. 2009;33(10):2022–7.CrossRefPubMed Christou NV. Impact of obesity and bariatric surgery on survival. World J Surg. 2009;33(10):2022–7.CrossRefPubMed
17.
Zurück zum Zitat Johannsen DL, Knuth ND, Huizenga R, et al. Metabolic slowing with massive weight loss despite preservation of fat-free mass. J Clin Endocrinol Metab. 2012;97(7):2489–96.CrossRefPubMedPubMedCentral Johannsen DL, Knuth ND, Huizenga R, et al. Metabolic slowing with massive weight loss despite preservation of fat-free mass. J Clin Endocrinol Metab. 2012;97(7):2489–96.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332(10):621–8.CrossRefPubMed Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332(10):621–8.CrossRefPubMed
19.
Zurück zum Zitat Knuth ND, Johannsen DL, Tamboli RA, et al. Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity (Silver Spring, Md). 2014;22(12):2563–9. Knuth ND, Johannsen DL, Tamboli RA, et al. Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity (Silver Spring, Md). 2014;22(12):2563–9.
20.
Zurück zum Zitat Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.CrossRefPubMed Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.CrossRefPubMed
21.
Zurück zum Zitat van de Laar A, de Caluwe L, Dillemans B. Relative outcome measures for bariatric surgery. Evidence against excess weight loss and excess body mass index loss from a series of laparoscopic roux-en-Y gastric bypass patients. Obes Surg. 2011;21(6):763–7.CrossRefPubMed van de Laar A, de Caluwe L, Dillemans B. Relative outcome measures for bariatric surgery. Evidence against excess weight loss and excess body mass index loss from a series of laparoscopic roux-en-Y gastric bypass patients. Obes Surg. 2011;21(6):763–7.CrossRefPubMed
22.
Zurück zum Zitat Sczepaniak JP, Owens ML, Shukla H, et al. Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008-2011. Obes Surg. 2015;25(5):788–95.CrossRefPubMed Sczepaniak JP, Owens ML, Shukla H, et al. Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008-2011. Obes Surg. 2015;25(5):788–95.CrossRefPubMed
23.
Zurück zum Zitat Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013 Nov;23(11):1922–33.CrossRefPubMed Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013 Nov;23(11):1922–33.CrossRefPubMed
24.
Zurück zum Zitat Group TSR. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef Group TSR. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef
25.
Zurück zum Zitat Switzer NJ, Merani S, Skubleny D, et al. Quality of follow-up: systematic review of the research in bariatric surgery. Ann Surg. 2016;263(5):875–80.CrossRefPubMed Switzer NJ, Merani S, Skubleny D, et al. Quality of follow-up: systematic review of the research in bariatric surgery. Ann Surg. 2016;263(5):875–80.CrossRefPubMed
26.
Zurück zum Zitat Dayer-Jankechova A, Fournier P, Allemann P, et al. Complications after laparoscopic roux-en-Y gastric bypass in 1573 consecutive patients: are there predictors? Obes Surg. 2016;26(1):12–20.CrossRefPubMed Dayer-Jankechova A, Fournier P, Allemann P, et al. Complications after laparoscopic roux-en-Y gastric bypass in 1573 consecutive patients: are there predictors? Obes Surg. 2016;26(1):12–20.CrossRefPubMed
27.
Zurück zum Zitat Finks JF, Kole KL, Yenumula PR, et al. Predicting risk for serious complications with bariatric surgery: results from the Michigan bariatric surgery collaborative. Ann Surg. 2011;254(4):633–40.CrossRefPubMed Finks JF, Kole KL, Yenumula PR, et al. Predicting risk for serious complications with bariatric surgery: results from the Michigan bariatric surgery collaborative. Ann Surg. 2011;254(4):633–40.CrossRefPubMed
28.
Zurück zum Zitat Ramanan B, Gupta PK, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012 Jun;214(6):892–900.CrossRefPubMed Ramanan B, Gupta PK, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012 Jun;214(6):892–900.CrossRefPubMed
29.
Zurück zum Zitat Faintuch J, Matsuda M, Cruz ME, et al. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 2004 Feb;14(2):175–81.CrossRefPubMed Faintuch J, Matsuda M, Cruz ME, et al. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 2004 Feb;14(2):175–81.CrossRefPubMed
30.
Zurück zum Zitat Banh L. Serum proteins as markers of nutrition: what are we treating? Pract Gastroenterol. 2006;30(10):46–64. Banh L. Serum proteins as markers of nutrition: what are we treating? Pract Gastroenterol. 2006;30(10):46–64.
Metadaten
Titel
Milestone Weight Loss Goals (Weight Normalization and Remission of Obesity) after Gastric Bypass Surgery: Long-Term Results from the University of Michigan
verfasst von
Corey J. Lager
Nazanene H. Esfandiari
Angela R. Subauste
Andrew T. Kraftson
Morton B. Brown
Ruth B. Cassidy
Darlene Bellers
Amy L. Lockwood
Oliver A. Varban
Elif A. Oral
Publikationsdatum
13.01.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 7/2017
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2533-1

Weitere Artikel der Ausgabe 7/2017

Obesity Surgery 7/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.